santhosh gopinath @santhoshgiyengar: "I TOLD YOU GUYS $MSFT..."

United Kingdom

I TOLD YOU GUYS $MSFT (Microsoft) results aren’t enough The market is currently in a policy vs. profits tug-of-war. If you aren’t paying attention to the macro shifts, your portfolio will become the casualty. I closed my Microsoft (MSFT) calls at the peak of $480 just before the 6% after-hours slide. Just lucky or because of price to perfection The Healthcare Repricing (UNH and CVS) There was no stock split. This is a fundamental repricing based on new policy. • $UNH (UnitedHealth) (UNH) dropped from $350 to $282. • $CVS (CVS Health Corp) Health (CVS) fell from $84 to $72. The catalyst is the Trump administration’s medical surcharge update. This is a direct hit to insurance margins, and it is changing the valuation models for the entire sector overnight. The Tech Beat and Bleed $MSFT exceeded earnings expectations on both revenue and EPS, yet the stock is down 6%. The reasons are clear: 1. Azure Guidance: Investors wanted evidence of accelerating growth, but the guidance suggested a steady pace instead. 2. Capital Expenditures: The $15 billion spent on AI infrastructure is beneficial for Nvidia, but shareholders are questioning the immediate return on investment for $MSFT own margins. What Is Next? I am holding some powder in fresh profit from the $MSFT exit and looking for the next entry point. • $TSLA (Tesla Motors, Inc.) (TSLA): Monitoring the $430 support level closely. • $NVDA (NVIDIA Corporation) (NVDA): The trend is still intact, but I am waiting for the post-Microsoft volatility to settle before adding to my $94k position. • $PLTR (Palantir Technologies Inc.) (PLTR): Technically oversold and remains a high-conviction recovery play. The lesson here is to avoid marrying your positions. Taking profits at $480 while sentiment was at its highest has provided the liquidity needed to buy the next major dip. Stay disciplined. Follow for the next move. #Investing #StockMarket #TradingStrategy #MSFT #NVDA #UNH #CVS #Tesla #AI